Description

Beligas Hypho-Viagra – Sildenafil Citrate 50 mg (50 Tablets)

Product Overview

Beligas Hypho-Viagra is a high-quality oral pharmaceutical preparation containing Sildenafil Citrate as its active substance. Each tablet provides 50 mg of sildenafil, the established and clinically validated active ingredient for the treatment of erectile dysfunction (ED). This product is manufactured by Beligas Pharmaceuticals, a recognized name in the pharmaceutical sector with a reputation for quality and reliability. Hypho-Viagra offers a convenient, discreet, and effective solution for men seeking to restore confidence and performance in their sexual health.

Sildenafil Citrate is a potent and selective inhibitor of phosphodiesterase type 5 (PDE5), the enzyme responsible for the degradation of cyclic guanosine monophosphate (cGMP) in the corpus cavernosum of the penis. By inhibiting PDE5, sildenafil enhances the nitric oxide-cGMP pathway, promoting smooth muscle relaxation and increased blood flow to the penile tissues during sexual stimulation. This mechanism enables men with erectile dysfunction to achieve and maintain erections sufficient for satisfactory sexual activity.

Since its initial approval by the U.S. Food and Drug Administration in 1998, sildenafil citrate has been the subject of more than 100 clinical trials involving over 8,000 men with erectile dysfunction, consistently demonstrating its efficacy and safety. The active half-life of sildenafil is approximately 3 to 5 hours, allowing for a window of effectiveness that supports spontaneous sexual activity.

Key Product Specifications

Mechanism of Action

Sildenafil citrate works by selectively inhibiting the PDE5 enzyme, which is found in high concentrations within the smooth muscle of the corpus cavernosum. During sexual arousal, nitric oxide is released, activating the enzyme guanylate cyclase, which increases levels of cyclic guanosine monophosphate (cGMP). cGMP causes relaxation of the smooth muscle cells, allowing increased blood inflow and resulting in an erection. By blocking the breakdown of cGMP, sildenafil prolongs and enhances this physiological response.

It is important to note that sildenafil requires sexual stimulation to be effective; it does not produce an erection in the absence of arousal. This selective action ensures that the medication works naturally with the body’s own physiological signals.

Clinical Efficacy and Safety

The efficacy of sildenafil citrate is well-documented in the medical literature. In a 12-week dose-escalation study, 69% of attempts at sexual intercourse were successful in men taking sildenafil, compared to only 22% in the placebo group. In a randomized, double-blind, placebo-controlled study, 82.5% of patients in the sildenafil group reported global efficacy assessment improvement, compared to 36.1% in the placebo group. Furthermore, in a long-term study, 88% of patients reported that sildenafil improved their erections.

Sildenafil has demonstrated effectiveness across a broad spectrum of etiologies, including organic, psychogenic, and mixed causes of erectile dysfunction. In patients with diabetes, sildenafil improved erectile function in 59% of cases; in patients with spinal cord injury, the success rate was 83%; and in patients with a history of radical prostatectomy, 43% experienced improvement.

The safety profile of sildenafil is well established. The most common adverse reactions, occurring in 2% or more of patients, include headache, flushing, dyspepsia, abnormal vision, nasal congestion, back pain, myalgia, nausea, dizziness, and rash. These effects are generally mild to moderate in intensity and transient in nature. In controlled clinical trials, the discontinuation rate due to adverse events was similar between sildenafil and placebo groups (2.5% and 2.3%, respectively).

Dosage and Administration

For most patients, the recommended starting dose of sildenafil is 50 mg, taken as needed approximately one hour before sexual activity. The tablet may be taken anywhere from 30 minutes to 4 hours before sexual activity. Based on individual effectiveness and tolerability, the dose may be increased to a maximum of 100 mg or decreased to 25 mg. The maximum recommended dosing frequency is once per day.

Hypho-Viagra is supplied as 50 mg tablets, providing a convenient starting dose that can be adjusted according to individual response. The product packaging contains 50 tablets, offering a substantial supply for ongoing use.

Contraindications and Warnings

Sildenafil citrate is contraindicated in patients who are using organic nitrates or nitric oxide donors in any form, as concomitant use can potentiate the hypotensive effects of nitrates and lead to severe hypotension. It is also contraindicated in patients with known hypersensitivity to sildenafil or any component of the tablet.

Patients should not use sildenafil if sexual activity is inadvisable due to their cardiovascular status. Patients should seek emergency medical attention if an erection lasts more than 4 hours (priapism). Sildenafil can potentiate the hypotensive effects of alpha-blockers and anti-hypertensive medications. Concomitant use with strong CYP3A4 inhibitors is not recommended.

Why Choose Beligas Hypho-Viagra?

Beligas Pharmaceuticals has established a reputation for producing high-quality pharmaceutical products. The company is known for its commitment to quality control and manufacturing standards. Hypho-Viagra offers the same active ingredient found in branded sildenafil products at a competitive price point, making effective erectile dysfunction treatment more accessible.

The 50 mg strength is the recommended starting dose for most patients, providing an optimal balance between efficacy and tolerability. The 50-tablet package offers excellent value and convenience for long-term use.

Take control of your sexual health and restore your confidence today. Beligas Hypho-Viagra 50 mg offers clinically proven efficacy, reliable quality, and outstanding value. Do not let erectile dysfunction affect your relationships and quality of life any longer.

Order Beligas Hypho-Viagra now at: https://anabolicsteroidsonline.shop/

---

Top 10 Frequently Asked Questions (FAQs)

1. What is Beligas Hypho-Viagra and what is it used for?

Beligas Hypho-Viagra is a pharmaceutical product containing Sildenafil Citrate 50 mg per tablet. It is used for the treatment of erectile dysfunction (ED) in adult men. Sildenafil helps men with ED achieve and maintain an erection sufficient for sexual activity when combined with sexual stimulation.

2. How does sildenafil citrate work?

Sildenafil works by inhibiting the phosphodiesterase type 5 (PDE5) enzyme, which breaks down cyclic guanosine monophosphate (cGMP) in the penile tissues. By blocking PDE5, sildenafil enhances the nitric oxide-cGMP pathway, promoting relaxation of smooth muscle and increased blood flow to the penis during sexual arousal. The medication requires sexual stimulation to be effective.

3. What is the recommended dosage for Hypho-Viagra?

The recommended starting dose for most patients is 50 mg, taken as needed approximately one hour before sexual activity. The tablet may be taken anywhere from 30 minutes to 4 hours before sexual activity. Based on effectiveness and tolerability, the dose may be increased to a maximum of 100 mg or decreased to 25 mg. The maximum recommended dosing frequency is once per day.

4. How long does sildenafil stay in the body?

Sildenafil has an elimination half-life of approximately 3 to 5 hours. The active half-life listed for Hypho-Viagra is 17.5 hours, which reflects the duration of its pharmacological activity. The medication can remain effective for up to 4 hours or more after dosing.

5. What are the common side effects of sildenafil?

The most common adverse reactions occurring in 2% or more of patients include headache, flushing, dyspepsia, abnormal vision, nasal congestion, back pain, myalgia, nausea, dizziness, and rash. These side effects are generally mild to moderate in intensity and transient. In clinical trials, the discontinuation rate due to adverse events was similar between sildenafil and placebo groups.

6. Who should not take sildenafil?

Sildenafil is contraindicated in patients using organic nitrates or nitric oxide donors in any form, as this combination can cause severe hypotension. It is also contraindicated in patients with known hypersensitivity to sildenafil or any tablet component. Patients should not use sildenafil if sexual activity is inadvisable due to cardiovascular status. Consult the full prescribing information for complete contraindications.

7. Can I take Hypho-Viagra with food?

Sildenafil may be taken with or without food. While food can slow the absorption of sildenafil and delay its onset of action, clinical studies have shown that no significant loss of efficacy occurs when sildenafil is taken shortly before or with a meal. For faster onset, it is recommended to take the tablet on an empty stomach.

8. Is sildenafil effective for all types of erectile dysfunction?

Sildenafil has demonstrated effectiveness across a broad spectrum of etiologies, including organic, psychogenic, and mixed causes of erectile dysfunction. In clinical studies, sildenafil improved erectile function in 59% of patients with diabetes, 83% of patients with spinal cord injury, and 43% of patients with a history of radical prostatectomy. Overall, 80% or more of men reported improved erections after treatment with PDE5 inhibitors.

9. How many tablets are in each package of Hypho-Viagra?

Each package of Beligas Hypho-Viagra contains 50 tablets, each tablet providing 50 mg of sildenafil citrate. This substantial quantity offers convenience and value for long-term use.

10. Where can I purchase Beligas Hypho-Viagra?

Beligas Hypho-Viagra can be purchased online through authorized retailers. Visit https://anabolicsteroidsonline.shop/ to place your order and take advantage of competitive pricing on this high-quality product.

---

References and Reputable Sources

• U.S. Food and Drug Administration (FDA) – Sildenafil Tablets Prescribing Information: https://www.accessdata.fda.gov

• DailyMed – Sildenafil Citrate Label Information: https://dailymed.nlm.nih.gov

• PubMed – Sildenafil Citrate Efficacy and Safety Studies: https://pubmed.ncbi.nlm.nih.gov

• PMC – Sildenafil Mechanism of Action: https://pmc.ncbi.nlm.nih.gov

• Australian Prescriber – Sildenafil Citrate Review: https://australianprescriber.tg.org.au

• European Medicines Agency (EMA) – Sildenafil Product Information: https://www.ema.europa.eu